# Inhaled Milrinone Use in Patients Receiving HeartMate II LVAD: A Pilot Study

> **NCT01571037** · PHASE1 · COMPLETED · sponsor: **University of Nebraska** · enrollment: 10 (actual)

## Conditions studied

- End Stage Heart Disease
- Right Ventricular Dysfunction

## Interventions

- **DRUG:** Inhaled, nebulized, Milrinone
- **DRUG:** inhaled nebulized milrinone

## Key facts

- **NCT ID:** NCT01571037
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04-05
- **Primary completion:** 2013-02-01
- **Final completion:** 2014-02-21
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-09-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01571037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01571037, "Inhaled Milrinone Use in Patients Receiving HeartMate II LVAD: A Pilot Study". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01571037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*